SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about disclosure

28 Feb 2025 Evaluate
In compliance with Regulation 30 of SEBI (LODR) Regulations, Sanofi India has submitted the disclosure regarding the Orders received from the following authorities, along with requisite details in accordance with the regulation: A. Order issued by the office of the Deputy Commissioner (ST), STU-3, Abids Division, Hyderabad. B. Order issued by the Assistant Commissioner Ghatak 21(Ahmedabad) Range 6 division 2 Gujarat C. Order issued by the Assistant Commissioner of State Tax, Cuttack-l, East Circle: Cuttack-I Odisha.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3587.20 8.65 (0.24%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×